Moderate to Severe Asthma: Journal Articles

• Asthma, SARS-CoV-2 and COVID-19 What have we learned about the interaction between asthma and COVID-19? Might asthma medications have an impact on outcomes?
  Current Opinion in Allergy and Clinical Immunology, March 18, 2021
• Advances in Allergen Immunotherapy for Asthma What have we learned about the benefits of allergen immunotherapy as a therapeutic option for asthma?
  Current Opinion in Allergy and Clinical Immunology, November 12, 2020
• Asthma Care Quality, Language, and Ethnicity in Children Do Latino children experience disparities for their asthma care management compared to non-Hispanic white children?
  Journal of the American Board of Family Medicine, October 15, 2020
• Efficacy of Benralizumab for Severe Eosinophilic Asthma A new study evaluates the efficacy of benralizumab for severe eosinophilic asthma in a real-life setting.
  BMC Pulmonary Medicine, October 07, 2020
• Serum Prednisolone and Corticosteroid Adherence in Asthma Serum prednisolone measurements may be an effective means of monitoring adherence to oral corticosteroid treatment in severe asthma patients.
  BMC Pulmonary Medicine, September 23, 2020
• Real-Life Experience With Benralizumab During 6 Months Do the benefits of benralizumab therapy for severe asthma demonstrated in clinical trials translate into real-world clinical practice?
  BMC Pulmonary Medicine, August 14, 2020
• Mortality Among Adults With Both Asthma and COPD Do patients with features of both asthma and chronic obstructive pulmonary disease have worse health outcomes than those with asthma or COPD alone?
  Morbidity & Mortality Weekly Report, July 27, 2020
• Outcomes and Lung Function in Children With Severe Asthma What have we learned about outcomes and lung function among children with uncontrolled severe asthma?
  BMC Pulmonary Medicine, May 06, 2020
• Home Visits for Children With Asthma Reduce Medicaid Costs The READY study evaluated the effect and the cost benefits of a community health worker-led home intervention on improving outcomes for Medicaid-enrolled children with uncontrolled asthma.
  Preventing Chronic Disease, April 06, 2020
• Age-Specific Incidence of Allergic and Non-Allergic Asthma A new study looks at the incidence of asthma among children and adults by evaluating age at onset and the role of childhood allergies.
  BMC Pulmonary Medicine, February 28, 2020
• Indoor Environmental Control Among Children With Asthma Indoor environmental control practices are effective in reducing asthma symptoms among children. How do these practices differ by race/ethnicity in households with children with asthma in the US?
  Preventing Chronic Disease, January 27, 2020
• Asthma/Obstructive Pulmonary Disease Overlap What is asthma/COPD overlap and how should it be treated? A new review discusses the identification and management of this condition.
  Current Opinion in Allergy and Clinical Immunology, January 10, 2020
• Mepolizumab for Severe Asthma With Chronic Rhinosinusitis Mepolizumab may be an effective treatment option for patients with severe asthma and underlying eosinophilic chronic rhinosinusitis.
  BMC Pulmonary Medicine, December 11, 2019
• Precision Medicine in Atopic Diseases What role might precision medicine have in the management of atopic diseases?
  Current Opinion in Allergy and Clinical Immunology, November 21, 2019
• Severe Asthma: An Update for 2019 This review focuses on the management of patients presenting with acute, poorly controlled asthma, highlighting therapeutic options for acute exacerbations and prevention.
  U.S. Pharmacist, September 05, 2019
• S. stercoralis Infection After Emergency Corticosteroids This case underscores that patients with apparent severe asthma exacerbation warrant careful evaluation before the initiation of corticosteroids, as not all wheezing is due to asthma.
  Journal of Medical Case Reports, May 29, 2019
• Elevated Serum OX40L and Corticosteroid Resistance in Asthma A new study explores the relationship between serum OX40L levels and corticosteroid response in children with asthma.
  BMC Pulmonary Medicine, May 07, 2019
• Severe Asthma in Children: Therapeutic Considerations Which factors should be considered before escalating treatments in children with severe therapy-resistant asthma?
  Current Opinion in Allergy and Clinical Immunology, March 20, 2019
• Reducing Corticosteroid-Related Adverse Events in Asthma The chronic use of corticosteroids is frequently associated with adverse events in asthmatics. What strategies may help reduce these events?
  Current Opinion in Allergy and Clinical Immunology, January 04, 2019
• Allergen Immunotherapy as Add-on to Biologic Agents A new review examines recent evidence regarding the addition of biological treatments to allergen-specific immunotherapy. What have we learned?
  Current Opinion in Allergy and Clinical Immunology, November 21, 2018